Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kazia (KZIA)

Logo korporat perusahaan Kazia Therapeutics Limited (KZIA)

Experienced management with deep R&D expertise ensures the steady development of Kazia Therapeutics (KZIA), which is reflected in the price action. The projected growth rate of net income per share visualizes the institutional development vector. Meanwhile, -56.00 determines the current status of the parameter. The business model relies on outsourcing brain tumor tests and fully transferring production to external contractors to minimize capital expenditures.

Kazia (KZIA): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 17.11.2026

Ringkesan rincian data analitis Kazia Therapeutics (KZIA)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Kazia Therapeutics Ltd
Produk dadi Kazia

The narrow specialization of Kazia Therapeutics (KZIA) in treating glioblastomas makes its financial results dependent on clinical trial outcomes. When analyzing the expected EPS trend for the coming year, an investor assesses the consensus earnings per share forecast, which serves as an indicator of cash flow predictability and a safeguard against overpaying for an asset with high fundamental volatility.

Analisis pesaing Kazia Therapeutics

INCY (incyte.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep hutch-med.com HCM|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvation Corp (NUVB)|DAWN - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Monopar Pharma MNPR|Inhibrx Corp - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMAB - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Fennec Pharmaceuticals|HRTX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Nuvectis NVCT|Prakiraan wutah bathi saben saham kanggo taun ngarep CHRS|Prakiraan wutah bathi resik saben saham ing taun ngarep Corbus Pharmaceuticals CRBP|Prakiraan wutah bathi saben saham kanggo taun ngarep CRDF (Cardiff Oncology Inc.)|BYSI (BeyondSpring) - Dinamika bathi saben saham sing diarepake ing taun ngarep|BioAtla - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep LIXT (Lixte Biotechnology Holdings, Inc.)|Citius Pharmaceuticals, Inc. - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep CLRB (Cellectar)|BLRX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep canfite.com (CANF)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep aprea.com|SLXN: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep NCNA|Prakiraan wutah bathi kanggo taun ngarep Chimerix Inc (CMRX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cyclacel Pharmaceuticals Inc. CYCC|GTHX (g1therapeutics.com) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|KRON: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Kintara Therapeutics Inc|oncternal.com (ONCT) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PRTG (Portage Biotech Corp)